Clinical Trials Directory

Trials / Unknown

UnknownNCT04219800

Reduced Occupational Sitting in Type 2 Diabetes Using mHealth (Mobile Health)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
142 (estimated)
Sponsor
Umeå University · Academic / Other
Sex
All
Age
40 Years – 64 Years
Healthy volunteers
Not accepted

Summary

Type 2 diabetes mellitus (T2DM) patients are suboptimal treated due to low uptake of physical activity. Recent research shows promising beneficial health effects from reducing sitting time by regular short bouts of light-intensity physical activity. These findings open up for a new focus in T2DM treatment but conclusive evidence is missing as studies have been short-term trials, mainly conducted in laboratory environments. Recent research suggest that reduced sitting and increased physical activity can be supported at a low cost by mHealth (mobile health) technology such as activity tracker armbands that warns of prolonged sitting and SMS text messages that reminds of activity breaks. The overarching purpose of the project is to evaluate the effects of an intervention aimed to reduce occupational sitting in T2DM using mHealth (mobile health). It is hypothesized that the intervention will lead to (1) Activity changes - reduced sitting time and/or increased number of steps (primary outcome measures) and (2) Health effects - lower fatigue, improved health-related quality of life, reduced cardiometabolic risk, less sick leave, less medication, less musculoskeletal problems (secondary outcome measures)

Conditions

Interventions

TypeNameDescription
BEHAVIORALPatient-centered counselling and written materialPatient-centered counselling and written material regarding occupational sedentary behaviour, with telephone follow-ups after 1 and 5 weeks.
BEHAVIORALmHealth1. Activity tracker armband (Garmin Vivofit); warns of prolonged sitting and counts daily steps. 2. SMS text messages; reminds of activity breaks. 3. Mobile video instruction for standing pause gymnastics.

Timeline

Start date
2020-12-08
Primary completion
2023-12-30
Completion
2024-12-30
First posted
2020-01-07
Last updated
2024-01-18

Locations

6 sites across 1 country: Sweden

Source: ClinicalTrials.gov record NCT04219800. Inclusion in this directory is not an endorsement.